Latest stories on NMRA
H.C. Wainwright reiterates Neumora stock rating on positive toxicology data
Investing.com Analyst Ratings61 · neutralanalyst
Neumora Therapeutics, Inc. (NMRA) files 8-K
SEC 8-K50 · neutralgeneral
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026 | NMRA Stock News
StockTitan67 · bullishproduct/pr
Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data
Yahoo Top58 · neutralproduct/pr
NMRA SHAREHOLDER INVESTIGATION: SueWallSt Investigates Neumora Therapeutics for Possible Securities Law Violations
PR Newswire28 · bearishgeneral
NMRA Facing Investor Scrutiny as Navacaprant Trials Miss Key Endpoints—Legal Investigation Launches Amid 35% Workforce Cut
MarketChameleon22 · bearishgeneral
Neumora depression drug fails; EnGene to cut 50% of staff
Yahoo Finance28 · bearishgeneral
NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials
Stocktwits News12 · bearishproduct/pr
Neumora plummets as phase 3 navacaprant data misses key goal
Seeking Alpha18 · bearishproduct/pr
Neumora Ends Navacaprant After Phase 3 Trial Failure
TipRanks15 · bearishproduct/pr
Neumora Therapeutics, Inc. (NMRA) files 8-K
SEC 8-K50 · neutralgeneral
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update | NMRA Stock News
StockTitan63 · neutralproduct/pr